Characterization of UPF peptides, members of the glutathione analogues library, on the basis of their effects on oxidative stress-related enzymes

Free Radical Research

Volumn 43, Issue 6, 2009, Pages 572-580

  Ehrlich, Kersti ^a   Ida, Katrin ^a   Mahlapuu, Riina ^a   Kairane, Ceslava ^a   Oit, Ingrid ^a   Zilmer, Mihkel ^a   Soomets, Ursel ^a  

^a UNIVERSITY OF TARTU   (Estonia)

Author keywords

Glutathione; Glutathione analogues; Glutathione peroxidase; Glutathione reductase; MnSOD; NAD(P)H oxidase; Oxidative stress

Indexed keywords

4 METHOXYTYROSINYL ALPHA GLUTAMYLCYSTEINYL GLYCINE; 4 METHOXYTYROSINYL GAMMA GLUTAMYLCYSTEINYL GLYCINE; GLUTATHIONE DERIVATIVE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MANGANESE SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

AGED; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN MITOCHONDRION; CONCENTRATION RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME PURIFICATION; GENE EXPRESSION; HEMOLYSATE; HUMAN; HUMAN CELL; HUMAN TISSUE; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANTIOXIDANTS; BRAIN; FREE RADICALS; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; LEUKOCYTES, MONONUCLEAR; MITOCHONDRIA; NADPH OXIDASE; OXIDATIVE STRESS; PEPTIDE LIBRARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SUPEROXIDE DISMUTASE;

EID: 67650882687     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760902918691     Document Type: Article

References (44)

1. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 1999;27:922-935.
2. Wu GY, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutrit 2004;134:489-492.
3. Dickinson DA, Forman HJ. Cellular glutathione and thiols metabolism. Biochem Pharmacol 2002;64:1019-1026.
4. Zilmer M, Soomets M, Rehema A, Langel U. The glutathione system as an attractive therapeutic target. Drug Design Reviews - Online.: Bentham Science Publishers: http://www.bentham.org/ddro/contabs/ddro2-2.htm. 2005;2:121-127.
5. Emerit J, Edeas M, Bricaire F. Neurodegenerative diseases and oxidative stress. Biomed Pharmacother 2004;58:39-46.
6. Franco R, Schoneveld OJ, Pappa A, Panayiotidis MI. The central role of glutathione in the pathophysiology of human diseases. Arch Physiol Biochem 2007;113:234-258.
7. Gate L, Paul J, Ba GN, Tew KD, Tapiero H. Oxidative stress induced in pathologies: The role of antioxidants. Biomed Pharmacother 1999;53:169-180.
8. Maher P. The effects of stress and aging on glutathione metabolism. Ageing Res Rev 2005;4:288-314.
9. Townsend DM, Tew KD, Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 2003;57:145-155.
10. Gaullier JM, Lafontant P, Valla A, Bazin M, Giraud M, Santus R. Glutathione-peroxidase and glutathione-reductase activities towards glutathione-derived antioxidants. Biochem Biophys Res Commun 1994;203:1668-1674.
11. Adang AE, Brussee J, van der GA, Mulder GJ. Inhibition of rat liver glutathione S-transferase isoenzymes by peptides stabilized against degradation by gamma-glutamyl transpeptidase. J Biol Chem 1991;266:830-836.
12. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001;30: 1191-1212.
13. Filomeni G, Rotilio G, Ciriolo MR. Cell signalling and the glutathione redox system. Biochem Pharmacol 2002;64: 1057-1064.
14. Yang MS, Chan HW, Yu LC. Glutathione peroxidase and glutathione reductase activities are partially responsible for determining the susceptibility of cells to oxidative stress. Toxicology 2006;226:126-130.
15. Chinta SJ, Rajagopalan S, Butterfield DA, Andersen JK. In vitro and in vivo neuroprotection by gamma-glutamylcysteine ethyl ester against MPTP: relevance to the role of glutathione in Parkinson's disease. Neurosci Lett 2006;402: 137-141.
16. Bharath S, Hsu M, Kaur D, Rajagopalan S, Andersen JK. Glutathione, iron and Parkinson's disease. Biochem Pharmacol 2002;64:1037-1048.
17. Sheu SS, Nauduri D, Anders MW. Targeting antioxidants to mitochondria: A new therapeutic direction. Biochim Biophys Acta 2006;1762:256-265.
18. Cadenas S, Cadenas AM. Fighting the stranger-antioxidant protection against endotoxin toxicity. Toxicology 2002;180: 45-63.
19. Victor VM, Rocha M, Esplugues JV, De la Fuente M. Role of free radicals in sepsis: Antioxidant therapy. Curr Pharm Des 2005;11:3141-3158.
20. Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003;24:471-478.
21. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: Role in cardiovascular biology and disease. Circ Res 2000;86:494-501.
22. Murdoch CE, Grieve DJ, Cave AC, Looi YH, Shah AM. NADPH oxidase and heart failure. Curr Opin Pharmacol 2006;6:148-153.
23. Van den Worm E, Beukelman CJ, Van den Berg AJ, Kroes BH, Labadie RP, Van Dijk H. Effects of methoxylation of apocynin and analogs on the inhibition of reactive oxygen species production by stimulated human neutrophils. Eur J Pharmacol 2001;433:225-230.
24. Ikeda Y, Young LH, Scalia R, Ross CR, Lefer AM. PR-39, a proline/ arginine-rich antimicrobial peptide, exerts cardioprotective effects in myocardial ischemia-reperfusion. Cardiovasc Res 2001;49:69-77.
25. Ehrlich K, Viirlaid S, Mahlapuu R, Saar K, Kullisaar T, Zilmer M, Langel U, Soomets U. Design, synthesis and properties of novel powerful antioxidants, glutathione analogues. Free Radic Res 2007;41:779-787.
26. Kals J, Starkopf J, Zilmer M, Pruler T, Pulges K, Hallaste M, Kals M, Pulges A, Soomets U. Antioxidant UPF1 attenuates myocardial stunning in isolated rat hearts. Int J Cardiol 2008;125:133-135.
27. Poder P, Zilmer M, Starkopf J, Kals J, Talonpoika A, Pulges A, Langel U, Kullisaar T, Viirlaid S, Mahlapuu R, Zarkovski A, Arend A, Soomets U. An antioxidant tetrapeptide UPF1 in rats has a neuroprotective effect in transient global brain ischemia. Neurosci Lett 2004;370:45-50.
28. Soomets U, Zilmer M, Langel Ü. Manual solid-phase synthesis of glutathione analogues: A laboratory-based short course. In: J Howl, editor. Peptide synthesis and applications. Totowa, NJ: Humana Press Inc.; 2005. p 241-257.
29. Rajapakse N, Shimizu K, Payne M, Busija D. Isolation and characterization of intact mitochondria from neonatal rat brain. Brain Res Brain Res Protoc 2001;8:176-183.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
31. Daiber A, August M, Baldus S, Wendt M, Oelze M, Sydow K, Kleschyov AL, Munzel T. Measurement of NAD(P)H oxidase-derived superoxide with the luminol analogue L-012. Free Radic Biol Med 2004;36:101-111.
32. Mollnau H, Schulz E, Daiber A, Baldus S, Oelze M, August M, Wendt M, Walter U, Geiger C, Agrawal R, Kleschyov AL, Meinertz T, Munzel T. Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. Arterioscler Thromb Vasc Biol 2003;23:615-621.
33. Imada I, Sato EF, Miyamoto M, Ichimori Y, Minamiyama Y, Konaka R, Inoue M. Analysis of reactive oxygen species generated by neutrophils using a chemiluminescence probe L-012. Anal Biochem 1999;271:53-58.
34. Vaher M, Viirlaid S, Ehrlich K, Mahlapuu R, Jarvet J, Soomets U, Kaljurand M. Characterization of the antioxidative activity of novel nontoxic neuropeptides by using capillary electrophoresis. Electrophoresis 2006;27:2582-2589.
35. Mahlapuu R, Vaher M, Ehrlich K, Kaljurand M, Soomets U. Comparison of the stability of glutathione and related synthetic tetrapeptides by HPLC and capillary electrophoresis. J Pept Sci 2006;12:796-799.
36. Matsuda Y, Higashiyama S, Kijima Y, Suzuki K, Kawano K, Akiyama M, Kawata S, Tarui S, Deutsch HF, Taniguchi N. Human liver manganese superoxide dismutase. Purification and crystallization, subunit association and sulfhydryl reactivity. Eur J Biochem 1990;194:713-720.
37. Amstad P, Moret R, Cerutti P. Glutathione peroxidase compensates for the hypersensitivity of Cu,Zn-superoxide dismutase overproducers to oxidant stress. J Biol Chem 1994;269:1606-1609.
38. Giorgio M, Trinei M, Migliaccio E, Pelicci PG. Hydrogen peroxide: A metabolic by-product or a common mediator of ageing signals? Nat Rev Mol Cell Biol 2007;8:722-728.
39. Nagata K, Iwasaki Y, Yamada T, Yuba T, Kono K, Hosogi S, Ohsugi S, Kuwahara H, Marunaka Y. Overexpression of manganese superoxide dismutase by N-acetylcysteine in hyperoxic lung injury. Respir Med 2007;101:800-807.
40. Seres T, Ravichandran V, Moriguchi T, Rokutan K, Thomas JA, Johnston RB, Jr. Protein S-thiolation and dethiolation during the respiratory burst in human monocytes. A reversible post-translational modification with potential for buffering the effects of oxidant stress. J Immunol 1996;156: 1973-1980.
41. Cross AR. Inhibitors of the leukocyte superoxide generating oxidase: mechanisms of action and methods for their elucidation. Free Radic Biol Med 1990;8:71-93.
42. Moriguchi T, Seres T, Ravichandran V, Sasada M, Johnston RB, Jr. Diamide primes neutrophils for enhanced release of superoxide anion: relationship to S-thiolation of cellular proteins. J Leukoc Biol 1996;60:191-198.
43. Janiszewski M, Pedro MA, Scheffer RC, van Asseldonk JH, Souza LC, da Luz PL, Augusto O, Laurindo FR. Inhibition of vascular NADH/NADPH oxidase activity by thiol reagents: Lack of correlation with cellular glutathione redox status. Free Radic Biol Med 2000;29:889-899.
44. Vejrazka M, Micek R, Stipek S. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS. production in nonphagocytic cells. Biochim Biophys Acta Gen Subj 2005;1722:143-147.